2024: University of California San Francisco (UCSF) Alumni Entrepreneur Award

Dr. Kelly Nguyen, CEO of DrKumo, received the University of California San Francisco (UCSF) Alumni Entrepreneur Award for demonstrating the highest caliber of innovation in Science and Health care through risk-taking actions value-creating transformations.

2023: DrKumo Awarded the U.S. Veterans Affairs $1 Billion National Contract with three other vendors for RPM-HT Tech Solutions

DrKumo Inc., a leading provider of Connected Health Technology Solutions, is pleased to announce that the company is one of the four winners who has been awarded the U.S. Department of Veterans Affairs’ (VA) eight-year, $1.032 billion-dollar national contract to provide Remote Patient Monitoring-Home Telehealth (RPM-HT) technology solutions.

2023: DrKumo Academy - Digital Training Platform

CalGrows Innovation Fund Grant Winner to provide DrKumo Certified Remote Patient Monitoring (RPM-HT) Connected Health Technology Program to CalGrows workforce training and development to the California State’s caregivers.

Pacific Asian Consortium in Employment (PACE) 2022 Entrepreneur Award

“DrKumo focuses on solutions and the highest good for all involved, and here at PACE, we value that! We are proud supporters of DrKumo and value what they bring to the table.” Susie Choy, Interim Assistant Director/Compliance Coordinator, PACE LA.

One of the 17 National Winners of 2020 US Department of Health and Human Services (HHS) OCS Grant via Partnership with PACE

DrKumo is recognized for its cutting-edge cloud-based technology that allows healthcare providers to remotely monitor their patients’ medical conditions and modify their treatment planning based on continuous real-time data.

CEO Dr. Kelly Nguyen, PharmD, North America 2020 Cartier Women Initiative Fellow

Dr. Kelly Nguyen was named 2020 North America Fellow, an annual international entrepreneurship competition that aims to drive change for social good. One of the vital criteria is to be a woman entrepreneur who has a strong and sustainable social or environmental impact.

Selected by FDA DSCSA Pilot Project Program to Address the Security of Drug Supply Chain, 2020

IDLogiq® (DrKumo’s former name) innovations have been selected by the Food and Drug Administration (FDA) for the Pilot Project Program under the Drug Supply Chain Security Act (DSCSA) to prototype and develop a system that can address the national security of the drug supply chain and future interoperability of secure electronic information exchange.

Magic Johnson Healthcare Award Nomination finalist

Dr. Kelly Nguyen, CEO of DrKumo, was nominated for demonstrating commitment to furthering diversity and technology in the healthcare arena.

GS1 Disruptive Innovation Startup Connect Award finalist

With GS1 calling for startups with new innovations and “disruptive technologies”, which would be promoted in the Startup Lab, IDLogiq came to the call as a startup with these unique disruptive technologies.